Literature DB >> 9516887

Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.

E J Threlfall1, A Graham, T Cheasty, L R Ward, B Rowe.   

Abstract

In 1996, 6% of Escherichia coli from extraintestinal infections were resistant to ciprofloxacin with minimum inhibitory concentrations (MICs) > or = 2 mg/l (high level resistance). Low level resistance (MIC 0.125-1 mg/l) was also identified in 7% of Salmonella typhi, 4% of S paratyphi A, and 4% of non-typhoidal salmonellas. However, resistance to ciprofloxacin was rarely identified in shigellas. For E coli, physicians should be aware that treatment failures may occur when patients with invasive illness are treated with ciprofloxacin before the results of laboratory sensitivity tests are available. For salmonellas an increasing number of treatment failures have been recorded for patients infected with strains with low level resistance. Because of the increasing incidence of Enterobacteriaceae with low level resistance to ciprofloxacin, it is recommended that for this group of organisms a breakpoint of 0.125 mg/l should be included in laboratory sensitivity tests.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9516887      PMCID: PMC500386          DOI: 10.1136/jcp.50.12.1027

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996.

Authors:  E J Threlfall; L R Ward; J A Skinner; B Rowe
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

2.  A case of ciprofloxacin-resistant typhoid fever.

Authors:  S Umasankar; R A Wall; J Berger
Journal:  Commun Dis Rep CDR Rev       Date:  1992-11-06

3.  Quinolone resistance in salmonella: clinical experience.

Authors:  L J Piddock; K Whale; R Wise
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

4.  High-level resistance to ciprofloxacin in Escherichia coli.

Authors:  E J Threlfall; T Cheasty; A Graham; B Rowe
Journal:  Lancet       Date:  1997-02-08       Impact factor: 79.321

5.  Ciprofloxacin-resistant Enterobacteriaceae.

Authors:  O M Murphy; C Marshall; D Stewart; R Freeman
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

6.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994.

Authors:  J A Frost; A Kelleher; B Rowe
Journal:  J Antimicrob Chemother       Date:  1996-01       Impact factor: 5.790

  7 in total
  7 in total

1.  Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Authors:  J Y Wang; M F Pasetti; F R Noriega; R J Anderson; S S Wasserman; J E Galen; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Ciprofloxacin resistant campylobacter.

Authors:  A Galloway; G Dickinson; M Harrison
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

3.  Salmonella enterica subsp. enterica isolated from chicken carcasses and environment at slaughter in Reunion Island: prevalence, genetic characterization and antibiotic susceptibility.

Authors:  Isabelle Henry; Sophie Granier; Céline Courtillon; Françoise Lalande; Marianne Chemaly; Gilles Salvat; Eric Cardinale
Journal:  Trop Anim Health Prod       Date:  2012-07-19       Impact factor: 1.559

4.  Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.

Authors:  N I Girgis; T Butler; R W Frenck; Y Sultan; F M Brown; D Tribble; R Khakhria
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

Authors:  A Hakanen; P Kotilainen; J Jalava; A Siitonen; P Huovinen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.

Authors:  B Malorny; A Schroeter; R Helmuth
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

7.  Prevalence and patterns of antimicrobial resistance of fecal Escherichia coil among pigs on 47 farrow-to-finish farms with different in-feed medication policies in Ontario and British Columbia.

Authors:  Holy T Akwar; Cornelis Poppe; Jeff Wilson; Richard J Reid-Smith; Monica Dyck; Josh Waddington; Dayue Shang; Scott A McEwen
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.